Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARDELYX, INC. Director's Dealing 2015

Feb 7, 2015

32003_dirs_2015-02-06_4d11d67a-b051-4bc7-b097-e4ae0c83d267.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2015-02-04

Reporting Person: Jacobs Jeffrey W (VP, Chemistry)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-04 Common Stock M 6416 $1.08 Acquired 53082 Direct
2015-02-04 Common Stock M 2472 $1.08 Acquired 55554 Direct
2015-02-04 Common Stock S 6388 $16.0746 Disposed 49166 Direct
2015-02-04 Common Stock S 2500 $16.8204 Disposed 46666 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-04 Stock Option (Right to Buy) $1.08 M 6416 Disposed 2021-02-17 Common Stock (6416) Direct
2015-02-04 Stock Option (Right to Buy) $1.08 M 2472 Disposed 2020-10-26 Common Stock (2472) Direct

Footnotes

F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 24, 2014.

F2: This transaction was executed in multiple trades in prices ranging from $15.64 to $16.64, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: This transaction was executed in multiple trades in prices ranging from $16.74 to $17.055, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: The option is fully vested and exercisable.